Asymptomatic Left Ventricular Systolic Dysfunction (Disorder), Heart Failure
Conditions
Brief summary
This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.
Interventions
A novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.
Sponsors
Study design
Eligibility
Inclusion criteria
* Primary care clinicians who are part of a participating care team that care for adult patients and have the ability to order ECG and TTE (this includes physicians, nurse practitioners, and physician assistants).
Exclusion criteria
* Primary care clinicians working in pediatrics, acute care, nursing homes, and resident care teams.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| New Diagnosis of Low Ejection Fraction (defined as ejection fraction ≤50%) | Within 90 days | Ejection fraction obtained by echocardiography. |
Countries
United States